Elke Schäffeler
Robert Bosch Hospital(DE)Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology(DE)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Acute Lymphoblastic Leukemia research, Inflammatory Bowel Disease, Helicobacter pylori-related gastroenterology studies, Hemoglobinopathies and Related Disorders
Most-Cited Works
- → NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression(2004)795 cited
- → The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells(2001)374 cited
- → Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.(2002)258 cited
- → Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease(2010)90 cited
- → GSTP1 and MDR1 Genotypes and Central Nervous System Relapse in Childhood Acute Lymphoblastic Leukemia(2005)54 cited
- → Impact of point-of-care testing for CYP2C19 on platelet inhibition in patients with acute coronary syndrome and early dual antiplatelet therapy in the emergency setting(2014)34 cited